GLP-1 drugs found to lower cancer risk in diabetes patients

FHS
July 9, 2024
2:22 am

Research finds that GLP-1 receptor agonists significantly reduce the risk of 10 out of 13 obesity-associated cancers in type 2 diabetes patients compared to insulins, but show varied results against metformin.

Avandra Launches with $17.75M to Create Largest Federated Network for De-Identified Medical Image Data

What You Should Know: – Avandra, the world’s largest federated network for medical imaging and clinical data, today announced it has raised $17.75 million to accelerate

February 17, 2025

WHO and Government of France host high-level meeting to combat meningitis

Global leaders highlight the need to defeat meningitis – a leading cause of disability – at a high-level meeting co-hosted by the World Health Organization

April 26, 2024

Peptide biotech MBX submits IPO plans, making a trio of post-Labor Day Nasdaq hopefuls

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.